Recruiting

Observational Study

Sponsor:

Appendix Cancer Pseudomyxoma Peritonei Research Foundation

Code:

NCT07769346

Conditions

Appendix Cancer

Pseudomyxoma Peritonei

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

ACPMP's first-ever patient-powered global patient registry/natural history study collects patient and caregiver information and data to fuel clinical trials and drive breakthroughs for appendix cancer and PMP. We've invested the time and resources to make our Registry regulatory grade. Our Registry operates under active, ongoing Institutional Review Board (IRB) oversight by independent ethicists. It is powered by NORD's IAMRARE®, an industry gold standard platform built to be consistent with FDA's best thinking on natural history studies.

Conditions

Appendix Cancer

Pseudomyxoma Peritonei

Study ID

NCT07769346

Start date

Feb 2, 2026

Status verified date

Aug, 2026

Completion date

Feb 1, 2030

Anticipated

Primary completion date

Feb 1, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of appendix cancer.
  • Meets the study inclusion criteria for participation.
  • Participant or, when applicable, a legally authorized representative (LAR) is able to provide informed consent and enter information into the Registry.
  • A designated representative may provide retrospective information for an individual who died from appendix cancer, as permitted by the study protocol.

Exclusion Criteria:

  • Individuals who do not meet the study inclusion criteria.
  • Individuals for whom required informed consent cannot be obtained.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants with Appendix Cancer and/or Pseudomyxoma Peritonei (PMP)

Individuals diagnosed with appendix cancer and/or Pseudomyxoma Peritonei (PMP) who enroll in the ACPMP Research Foundation Appendix Cancer/PMP Patient Registry. Participants, caregivers, or authorized representatives provide health and disease-related information through online surveys and may periodically update their information over time.

Primary outcome measure

  • Natural history and clinical course of appendix cancer and Pseudomyxoma Peritonei (PMP) [ Time Frame: Up to 5 years ]

Central Contacts and Locations

Central contacts

Margaret Najarian

(833) 227-6773patientregistry@acpmp.org

Locations

ACPMP

Recruiting

Springfield, Pennsylvania, United States, 19064

Contacts

Margaret Najarian Patient Registry Coordinator

(833) 227-6773patientregistry@acpmp.org

More Information

Sponsor

Appendix Cancer Pseudomyxoma Peritonei Research Foundation

Last update posted

Aug 17, 2026

Last verified

Aug, 2026

Keywords

  • Appendix Cancer
  • Appendiceal Cancer
  • Appendiceal Neoplasm
  • Appendiceal Neoplasms
  • Appendiceal Adenocarcinoma
  • Pseudomyxoma Peritonei
  • PMP
  • Peritoneal Surface Malignancy
  • Peritoneal Surface Malignancies
  • Patient Registry
  • Rare Cancer
  • Natural History Study
  • Natural History
  • Goblet Cell
  • Signet Ring Cell
  • LAMN
  • Low-Grade Appendiceal Mucinous Neoplasm
  • High-Grade Appendiceal Mucinous Neoplasm
  • HAMN

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Appendix Cancer Pseudomyxoma Peritonei Research Foundation on 2026-08-17.